Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCBX.L Regulatory News (CBX)

  • There is currently no data for CBX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on ingestibles product range

22 Apr 2022 18:04

RNS Number : 1183J
Cellular Goods PLC
22 April 2022
 

The information contained within this announcement is deemed by the Company to constitute inside

information stipulated under the Market Abuse Regulation (EU) No. 596/2014, as retained as part of

the law of England and Wales. Upon the publication of this announcement via the Regulatory

Information Service, this inside information is now considered to be in the public domain.

 

 

Press release

 

22 April 2022

 

Cellular Goods PLC

 

('Cellular Goods' or 'the Company')

 

Update on ingestibles product range

 

Further to the announcement of 13 April 2022, the Company has now received correspondence from Trading Standards and has agreed to suspend sales of its ingestibles range with immediate effect.

 

The Company is disappointed with this development and will continue to engage with the Food Standards Agency (FSA) given its ingestible products are identical to products which are entitled to remain on the market.

 

While the Company believes that ingestibles are an important part of the overall market, Cellular's product marketing activity to date has focused on the non-ingestible products in the Company's 'Look Better' skincare range which remains unaffected.

 

Anna Chokina, Chief Executive Officer of Cellular Goods, said: "We are disappointed by the FSA's stance. We will continue to engage with the regulator as we believe our products are safe, of a high quality and appropriate to be on the market. We hope the matter can be resolved soon."

 

 

For further information please contact:

Cellular Goods

Anna Chokina

Chief Executive

Neil Thapar

Investor Relations

via Tancredi +44 207 887 7633

 

+44 787 645 5323

Tennyson Securities

Corporate Broker

Peter Krens

 

+44 207 186 9030

Novum Securities

Corporate Broker

Colin Rowbury

Jon Belliss

 

 

+44 207 399 9427 

Tancredi Intelligent Communication

Media Relations

Helen Humphrey

Gabriela Amaya Garcia

Charlie Hobbs

cellulargoods@tancredigroup.com

 

+44 744 922 6720

+44 791 503 5294

+44 789 755 7112

 

About Cellular Goods PLC:

Cellular Goods is a UK-based wellness company that provides premium products based on lab-made cannabinoids. It was established in August 2018 to develop efficacy-led and research-backed cannabinoid-powered wellness products. The initial focus is on three product verticals: Function Better, Feel Better and Look Better. These three verticals encompass Cellular Goods' premium CBG skincare and CBD ingestible and topical athletic recovery products, with the first products launched in December 2021 initially through the Company's website. The Company's shares are listed on the main market of the London Stock Exchange. www.cellular-goods.com 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDSEEFWEEESESL
Date   Source Headline
19th Jan 20247:00 amRNSNotice of Annual General Meeting
15th Jan 20247:00 amRNSDirector's Dealings
12th Jan 20247:00 amRNSDirector's Dealings
11th Jan 20247:00 amRNSChange of name and Focus on AI Beauty Opportunity
10th Jan 20247:00 amRNSDirector's Dealings
9th Jan 20247:00 amRNSDirector's Dealings
8th Jan 20247:00 amRNSChanges in Board Composition
3rd Jan 20245:22 pmRNSTR-1: Notification of major holdings
22nd Dec 20237:00 amRNSAnnual Results for the Year Ended 31 August 2023
5th Dec 20237:00 amRNSCellular Goods launch luxury festive gift sets
30th Nov 20234:05 pmRNSRejuvenating Face Serum receives Bronze Award
29th Nov 202312:15 pmRNSCellular Goods open shipping to 3 more EU markets
29th Nov 20237:00 amRNSCellular Goods nominated in Get The Gloss Awards
16th Nov 20237:00 amRNSCellular Goods open shipping to 4 more EU markets
15th Nov 20237:00 amRNSCellular Goods' products to launch on Chill.com
13th Nov 20237:00 amRNSKing Tide Carbon produce kelp-derived biochar
8th Nov 20237:00 amRNSCellular Goods product in Jamie Greenberg Swag Bag
6th Nov 20237:00 amRNSCellular Goods participate in Sephora’s Beauty Box
1st Nov 20237:00 amRNSCellular Goods open shipping to France and Germany
18th Oct 20237:00 amRNSCellular Goods launch in Sephora's sample programs
11th Oct 20237:00 amRNSKing Tide Carbon form JV with Springtide Seaweed
21st Sep 20237:00 amRNSCellular Goods is a finalist in Pure Beauty Awards
1st Aug 20237:00 amRNSCellular Goods open sales in France and Germany
17th Jul 20237:00 amRNSKing Tide Carbon Sign MOU with Springtide Seaweed
14th Jul 20236:23 pmRNSTR-1: Standard form for notification
19th Jun 20237:00 amRNSPayment partnership with Klarna
12th Jun 20236:15 pmRNSCorrection: Grant of Warrants
9th Jun 20237:00 amRNSGrant of Warrants
17th May 20237:00 amRNSProducts live on Sephora
12th May 20235:33 pmRNSDirector Dealings & TR-1 Notifications
10th May 20235:48 pmRNSGrant of Warrants
10th May 20237:00 amRNSProducts to launch on Sephora.co.uk
9th May 20237:00 amRNSAcquisition Completion
5th May 20237:00 amRNSInterim results
3rd May 20237:00 amRNSNotice of half-year results
4th Apr 20235:12 pmRNSGrant of Options and Warrants
1st Mar 20232:05 pmRNSSecond Price Monitoring Extn
1st Mar 20232:00 pmRNSPrice Monitoring Extension
13th Feb 20235:50 pmRNSResults of Annual General Meeting
8th Feb 20237:00 amRNSTermination of proposed acquisition
2nd Feb 20237:00 amRNSAnnual General Meeting Update
31st Jan 20235:25 pmRNSTR-1: Standard notification of major holdings
24th Jan 20235:36 pmRNSTR-1: Standard notification of major holdings
19th Jan 20234:47 pmRNSNotice of Annual General Meeting
17th Jan 20234:49 pmRNSTR-1: Standard notification of major holdings
6th Jan 20235:04 pmRNSBoard changes
5th Jan 20234:57 pmRNSTR-1: Standard notification of major holdings
5th Jan 20234:56 pmRNSTR-1: Standard notification of major holdings
3rd Jan 20232:05 pmRNSSecond Price Monitoring Extn
3rd Jan 20232:00 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.